{
    "eid": "2-s2.0-85128341037",
    "title": "5-O-(N-Boc-L-Alanine)-Renieramycin T Induces Cancer Stem Cell Apoptosis via Targeting Akt Signaling",
    "cover-date": "2022-04-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology, Toxicology and Pharmaceutics (miscellaneous)",
            "@code": "3001",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "5-O-(N-Boc-L-alanine)-renieramycin T",
        "Akt",
        "anti-cancer",
        "apoptosis",
        "c-Myc",
        "cancer stem cells",
        "lung cancer",
        "marine sponge",
        "Xestospongia sp"
    ],
    "authors": [
        "Darinthip Suksamai",
        "Satapat Racha",
        "Nicharat Sriratanasak",
        "Chatchai Chaotham",
        "Kanokpol Aphicho",
        "Aye Chan Khine Lin",
        "Chaisak Chansriniyom",
        "Khanit Suwanborirux",
        "Supakarn Chamni",
        "Pithi Chanvorachote"
    ],
    "citedby-count": 8,
    "ref-count": 45,
    "ref-list": [
        "Cancer Stem Cells\u2014Perspectives and How to Target Them",
        "Therapeutic approaches targeting cancer stem cells",
        "Therapies targeting cancer stem cells: Current trends and future challenges",
        "The MYC oncogene is a global regulator of the immune response",
        "C-myc Contributes to Malignancy of Lung Cancer: A Potential Anticancer Drug Target",
        "The PI3K/AKT/c-MYC Axis Promotes the Acquisition of Cancer Stem-Like Features in Esophageal Squamous Cell Carcinoma",
        "Targeting the PI3K/Akt/mTOR pathway in non-small cell lung cancer (NSCLC)",
        "Efficacy and safety of trabectedin or dacarbazine for metastatic liposarcoma or leiomyosarcoma after failure of conventional chemotherapy: Results of a phase III randomized multicenter clinical trial",
        "Lurbinectedin (PM01183), a selective inhibitor of active transcription, effectively eliminates both cancer cells and cancer stem cells in preclinical models of uterine cervical cancer",
        "Trabectedin is active against malignant pleural mesothelioma cell and xenograft models and synergizes with chemotherapy and Bcl-2 inhibition in vitro",
        "Yondelis\u00ae (ET-743, Trabectedin) sensitizes cancer cell lines to CD95-mediated cell death: New molecular insight into the mechanism of action",
        "Ecteinascidin 770, a tetrahydroisoquinoline alkaloid, sensitizes human lung cancer cells to anoikis",
        "Chemistry and biology of the tetrahydroisoquinoline antitumor antibiotics",
        "Renieramycin-type alkaloids from marine-derived organisms: Synthetic chemistry, biological activity and structural modification",
        "Renieramycin M sensitizes anoikis-resistant H460 lung cancer cells to anoikis",
        "Chemistry of renieramycins. Part 13: Isolation and structure of stabilized renieramycin type derivatives, renieramycins W\u2013Y, from Philippine blue sponge Xestospongia sp., pretreated with potassium cyanide",
        "Renieramycin m attenuates cancer stem cell-like phenotypes in h460 lung cancer cells",
        "Phthalascidin, a synthetic antitumor agent with potency and mode of action comparable to ecteinascidin 743",
        "Chemistry of renieramycins. Part 19: Semi-syntheses of 22-O-amino ester and hydroquinone 5-O-amino ester derivatives of renieramycin M and their cytotoxicity against non-small-cell lung cancer cell lines",
        "Apoptosis-inducing effect of hydroquinone 5-O-cinnamoyl ester analog of renieramycin M on non-small cell lung cancer cells",
        "Hydroquinone 5-O-Cinnamoyl Ester of Renieramycin M Suppresses Lung Cancer Stem Cells by Targeting Akt and Destabilizes c-Myc",
        "Chemistry of renieramycins. Part 7: Renieramycins T and U, novel renieramycin\u2013ecteinascidin hybrid marine natural products from Thai sponge Xestospongia sp",
        "Renieramycin T Induces Lung Cancer Cell Apoptosis by Targeting Mcl-1 Degradation: A New Insight in the Mechanism of Action",
        "5-O-Acetyl-Renieramycin T from Blue Sponge Xestospongia sp. Induces Lung Cancer Stem Cell Apoptosis",
        "Stereoselective total synthesis of (\u2212)-renieramycin T",
        "A Scalable Total Synthesis of the Antitumor Agents Et-743 and Lurbinectedin",
        "Knowledge-guided docking: Accurate prospective prediction of bound configurations of novel ligands using Surflex-Dock",
        "Photoredox reactions of quinones",
        "ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response",
        "The anti-apoptotic protein MCL1, a novel target of lung cancer therapy",
        "Proliferation, survival and metabolism: The role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination",
        "Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells",
        "PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomas",
        "Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activity",
        "Pluripotency transcription factors and cancer stem cells: Small genes make a big difference",
        "Polyphenolic Proanthocyanidin-B2 suppresses proliferation of liver cancer cells and hepatocellular carcinogenesis through directly binding and inhibiting AKT activity",
        "Targeting the Akt1 allosteric site to identify novel scaffolds through virtual screening",
        "Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition",
        "Preparation of Tricyclic Analog As Cde Ring Model of Renieramycin Marine Natural Product by Novel Photo-Induced Transformation of 6-Methoxy-1,2,3,4-Tetrahydroisoquinoline-5,8-Dione (Dedicated to Professor Tohru Fukuyama on the occasion of his 70th birthday)",
        "Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl) pyridin-2-amine (ARQ 092): An orally bioavailable, selective, and potent allosteric AKT inhibitor",
        "RCSB Protein Data Bank: Powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences",
        "UCSF ChimeraX: Structure visualization for researchers, educators, and developers",
        "AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility",
        "AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "National Research Council of Thailand"
    ]
}